Benzphetamine drug data and news

Benzphetamine drug data, resources, and news articles (when available). Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006.

Generic name Benzphetamine
Brand Names/Synonyms Benzfetamine; Benzphetamine; Benzylamphetamine; Didrex
Indication For the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction
Sponsored links
Description Not Available
Pharmacology Benzphetamine, a phenylalkylamin, is related to amphetamine both chemically and pharmacologically. It is an anorectic agent indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction. Benzphetamine is a sympathomimetic amine with pharmacologic activity similar to the prototype drugs of this class used in obesity, the amphetamines. Actions include central nervous system stimulation and elevation of blood pressure. Tachyphylaxis and tolerance have been demonstrated with all drugs of this class in which these phenomena have been looked for.
Mechanism Of Action Although the mechanism of action of the sympathomimetic appetite suppressants in the treatment of obesity is not fully known, these medications have pharmacological effects similar to those of amphetamines. Amphetamine and related sympathomimetic medications (such as benzphetamine) are thought to stimulate the release of norepinephrine and/or dopamine from storage sites in nerve terminals in the lateral hypothalamic feeding center, thereby producing a decrease in appetite. This release is mediated by the binding of benzphetamine to centrally located adrenergic receptors.
Benzphetamine News
(When available)
[an error occurred while processing this directive]
Dosage Forms TABLET (SCORED)
Drug_Category Adrenergic Agents; Dopamine Agents; Central Nervous System Agents; ATC:A08AA
Absorption Readily absorbed from the gastro-intestinal tract and buccal mucosa. It Is resistant to metabolism by monoamine oxidase.
Interactions Interactions for Benzphetamine:

Hypertensive crises have resulted when sympathomimetic amines have been used concomitantly within14 days following use of monoamine oxidase inhibitors. DIDREX should not be used concomitantly with other CNS stimulants.

Amphetamines may decrease the hypotensive effect of antihypertensives. Amphetamines may enhance the effects of tricyclic antidepressants.

Urinary alkalinizing agents increase blood levels and decrease excretion of amphetamines. Urinary acidifying agents decrease blood levels and increase excretion of amphetamines.

Toxicity Oral, rat LD50: 160 mg/kg. Acute overdosage may result in restlessness, tremor, tachypnea, confusion, assaultiveness, and panic states.
Organisms Affected Humans and other mammals
Chemical IUPAC Name N-benzyl-N-methyl-1-phenyl-propan-2-amine
Chemical Formula C17H21N
Molecular Weight 239.355 g/mol
Smiles String CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2
Melting Point 152-153 °C
Water Solubility Readily soluble
State Solid (white crystalline powder)
LogP/Hphobicity 4.374
Isoelectric Point Not Available
Biotransformation Hepatic. Benzphetamine's metabolites include amphetamine and methamphetamine.
Half Life 16 to 31 hours
Protein Binding [%] 75-99%
RxList Link RXlist
Sponsored links
Drug Reference http://www.drugs.com/cons/Benzphetamine.html
http://www.rxlist.com/cgi/generic/benzphet.htm
Drug Type Approved Drug
Accession No APRD00759
CAS Registry Number 156-08-1
KEGG Compound ID C07538
PubChem ID SID:152260
PharmGKB ID PA448586
SwissProt ID Not Available
GenBank ID Not Available
Drug ID Number [DIN] Not Available

Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org